As shown in Table 1, 18 studies [8–25] investigated the association between DCLK1 expression and clinicopathological characteristics in patients with cancer from 2012 to 2017, containing a total of 2660 patients with the sizes of studies distributing from 23 [18] to 1132 [10] patients. The gene discussed is DCLK1; the disease is cancer.